Corporate Presentation
Market Opportunity: Retail Revenue Potential Sensitivity
150,000 kg Annual Capacity Increasing to 250,000 kg by Q2/19
Facility Capacity (Flower)
Capacity Utilization
Process Throughput (Flower)
Flower to active cannabinoid
conversion (Note A)
Active Cannabinoid Content
Active Cannabinoid Content
Price per active component
(Note B)
Revenue at retail per annum
(kg)
(%)
(kg)
(%)
(kg)
(mg) M
(mg)
($) B
150,000
50%
75,000
10%
7,500
7,500M
$0.11
$0.880B
150,000
100%
150,000
10%
15,000
15,000M
$0.11
$1.65B
250,000
50%
125,000
10%
12,500
12,500M
$0.11
$1.37B
Note A
Cannabinoid recovery from flower ranges between
10% - 20%; active cannabinoid concentration in
crude ranges from 70% - 80%
Note B
Source: Based on aggregated pricing data per mg
on Harvest Medicine website:
https://hmed.ca/pricewatch/ ranging between
$0.10- $0.12 per mg.
Potential retail revenue is not reflective of future
revenue guidance or management expectations
for actual financial results.
Pricing reflects retail pricing to end consumer in
Canadian market inclusive of excise tax of
approximately 10%.
MediPharm Labs | 11View entire presentation